{"id":1929,"date":"2020-06-30T10:33:18","date_gmt":"2020-06-30T09:33:18","guid":{"rendered":"https:\/\/targetmalaria.org\/?p=1929"},"modified":"2025-12-11T12:51:11","modified_gmt":"2025-12-11T12:51:11","slug":"happy-15th-anniversary-u-s-presidents-malaria-initiative","status":"publish","type":"post","link":"https:\/\/targetmalaria.org\/fr\/latest\/blog\/happy-15th-anniversary-u-s-presidents-malaria-initiative\/","title":{"rendered":"Happy 15th Anniversary, U.S. President\u2019s Malaria Initiative!"},"content":{"rendered":"\n

On<\/span> June 30th<\/sup>, the <\/span>U.S. President\u2019s Malaria Initiative (PMI)<\/span><\/a> is<\/span> celebrating its 15th Anniversary. PMI, one of the most prominent organisations fighting malaria worldwide, was created by the former-US President George W. Bush, back in 2005. Since then, the initiative has been working to give children a healthy childhood and break the cycle of disease and poverty in places where malaria is endemic.\u202f <\/span><\/p>\n\n\n\n

During the last 15 years<\/span>, PMI played a vital role in providing financial and technical resources. In 2019 alone, they spent USD$ 729 million in initiatives across 24 countries in Africa and three different programmes on the Greater Mekong Subregion in South East Asia. Altogether, these regions represent 90% of the global malaria burden<\/span>.<\/span> <\/span> <\/span><\/p>\n\n\n\n

Together with its partners, PMI has helped save over seven millionlives and prevent more than a billion malaria cases. Due to the progress against malaria, a child has a better chance of survival today than at any other time in history. PMI has played a vital role in this process: 22 partner countries in sub-Saharan Africa registered reductions from 10% to 67% in all-mortality rates in children under five years.<\/span><\/p>\n\n\n\n

PMI\u2019s focus on capacity building and infrastructure <\/span>has helped<\/span> improve<\/span> health care systems<\/span> and generated<\/span> a high return on investment<\/span>.<\/span> The <\/span>initiative pioneered new approaches: i<\/span>n partnership with the Global Fund, PMI helped to make artemisinin combination therapy (ACTs) a first-line treatment<\/span>; <\/span>i<\/span>t also introduced rapid diagnostic testing (RDTs) at both the facility and community level, shifting away from presumptive treatment.<\/span> <\/span><\/p>\n\n\n\n

Since 2005, the <\/span>organisation <\/span>has <\/span>distributed<\/span>:<\/span> <\/span><\/p>\n\n\n\n